Short answer
ANI PHARMACEUTICALS INC (ANIP) filed its Q1 2026 10-Q quarterly report on May 8, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $237M (up 20.5% year over year) with net income of $29M.
Q1 2026 key financials · XBRL
- Revenue
- $237M
- +20.5% YoY
- Net income
- $29M
- +88.1% YoY
- Operating margin
- 16.4%
- EPS (diluted)
- $1.28
- +85.5% YoY
Source: XBRL data from the ANI PHARMACEUTICALS INC (ANIP) Q1 2026 10-Q on SEC EDGAR. USD.
ANI PHARMACEUTICALS INC Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- Risk Factors section not provided; no new or changed risks identifiable
- Insider trading-plan activity: four executives and directors authorized sales of up to 399,138 shares
- Employee withholding-related share transfers: 260,194 shares purchased at average $75.92 during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other ANI PHARMACEUTICALS INC quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.